Fermata Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,137
| Closed | -$238K | – | 221 |
|
|
2025
Q1 | $238K | Sell |
1,137
-25
| -2% | -$5.24K | 0.04% | 243 |
|
|
2024
Q4 | $206K | Buy |
1,162
+5
| +0.4% | +$888 | 0.04% | 255 |
|
|
2024
Q3 | $229K | Sell |
1,157
-285
| -20% | -$56.3K | 0.05% | 221 |
|
|
2024
Q2 | $247K | Sell |
1,442
-27
| -2% | -$4.63K | 0.06% | 188 |
|
|
2024
Q1 | $267K | Sell |
1,469
-203
| -12% | -$37K | 0.06% | 176 |
|
|
2023
Q4 | $259K | Sell |
1,672
-48
| -3% | -$7.44K | 0.06% | 147 |
|
|
2023
Q3 | $257K | Buy |
+1,720
| New | +$257K | 0.07% | 135 |
|
|
2022
Q3 | – | Sell |
-2,239
| Closed | -$343K | – | 132 |
|
|
2022
Q2 | $343K | Sell |
2,239
-313
| -12% | -$48K | 0.12% | 118 |
|
|
2022
Q1 | $414K | Sell |
2,552
-58
| -2% | -$9.41K | 0.16% | 104 |
|
|
2021
Q4 | $353K | Buy |
2,610
+27
| +1% | +$3.65K | 0.13% | 115 |
|
|
2021
Q3 | $279K | Buy |
2,583
+286
| +12% | +$30.9K | 0.12% | 128 |
|
|
2021
Q2 | $259K | Buy |
+2,297
| New | +$259K | 0.15% | 116 |
|